Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets

A Mushtaq, P Wu, MM Naseer - Pharmacology & Therapeutics, 2024 - Elsevier
Cancer, a noncommunicable disease, is the leading cause of mortality worldwide and is
anticipated to rise by 75% in the next two decades, reaching approximately 25 million cases …

A concise review on recent development of indole derivatives for anticancer activities

BT Sridhar, NG Yernale, RS Gani, N Gupta… - Journal of the Indian …, 2024 - Elsevier
Indole heterocycles have been considered as noteworthy associated hybrids because of
their diverse applications in organic synthesis, and coordination chemistry, as well as in the …

Development of chromone-thiazolidine-2, 4-dione Knoevenagel conjugates as apoptosis inducing agents

MS Galla, NB Kale, A Sharma, A Hajare… - Bioorganic & Medicinal …, 2024 - Elsevier
Overexpression of Bcl-2 protein is a predominant hallmark of disturbed apoptotic pathway in
most of the cancers. Herein, chromone-linked thiazolidinediones were designed and …

Development of 3-indolyl substituted phenyl pyrazolo-carboxamide hybrids as potential type II VEGFR-2 inhibitors and in vitro cytotoxicity studies

DG Valapil, G Devabattula, AS Barahdia… - Bioorganic & Medicinal …, 2025 - Elsevier
The progression of tumors is intricately linked to angiogenesis, the formation of new blood
vessels, driven primarily by the release of growth factors such as Vascular Endothelial …